Advisor Net Financial, Inc Seagen Inc. Transaction History

Advisor Net Financial, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	SELL	$191.51 - $216.16 $1,340 - $1,513	-7 Reduced 30.43%	16 $3,000
Q1 2023 Apr 28, 2023	BUY	$127.59 - $203.08 $127 - $203	1 Added 4.55%	23 $4,000
Q4 2022 Jan 13, 2023	BUY	$117.37 - $139.17 $1,408 - $1,670	12 Added 120.0%	22 $0
Q2 2022 Jul 07, 2022	BUY	$108.81 - $179.33 $1,088 - $1,793	10 New	10 $2,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.